IP Library Granted Patent US 8,876,860
Granted Patent B2
US 8,876,860 · App. 12/405,087 · Granted Nov 4, 2014

Vascular closure device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,876,860
App. No.
12/405,087
Granted
Nov 4, 2014
Kind
B2
Abstract

The present invention provides a porous structure that works very effectively to seal a puncture site with optimum porosity, absorbent capacity and perfect anatomical fit. The plug density and other fiber properties/geometry (total denier; number of filaments; etc) have provided an efficient structure that allows instantaneous absorption of blood during deployment. The final size of the plug with absorbed fluids provides an anatomical fit and seals the puncture site within few minutes after deployment.

Claims (11)

1. An implantable medical device comprising:

a preformed, compressible, cylindrically shaped, porous fibrous structure configured for deployment in extra-vascular tissue to seal a passage through tissue communicating with a body lumen, the fibrous structure formed from at least one randomly oriented fiber comprising at least one polymer, the fibrous structure having a porosity ranging from 68% when the porous fibrous structure is in a compressed, pre-deployed configuration to 97% when the porous fibrous structure is in an uncompressed, deployed configuration.

2. The implantable medical device of claim 1 wherein the fibrous structure has a porosity ranging from 81 to 98%.

3. An implantable medical device comprising:

a preformed, compressible, cylindrically shaped, porous fibrous structure configured for deployment in extra-vascular tissue to seal a passage through tissue communicating with a body lumen, the fibrous structure formed from at least one randomly oriented fiber comprising at least one polymer, the fibrous structure having an absorbent capacity ranging from 2.75 g/g when the porous fibrous structure has a density of approximately 0.35 g/cc to 3.3 g/g when the porous fibrous structure has a density of approximately 0.45 g/cc.

4. An implantable medical device comprising:

a preformed, compressible, cylindrically shaped, porous fibrous structure configured for deployment in extra-vascular tissue to seal a passage through tissue communicating with a body lumen, the fibrous structure formed from at least one randomly oriented fiber comprising at least one polymer, the fibrous structure having a density ranging from 0.5 g/cc when the porous fibrous structure is in a compressed, pre-deployed configuration to 0.05 g/cc when the porous fibrous structure is in an uncompressed, deployed configuration.

5. The implantable medical device of claim 1 , 3 or 4 wherein:

the randomly oriented fiber comprises at least one polymer with an absorption time varying from 30 to 90 days.

6. The implantable medical device of claim 1 , 3 , 4 or 5 wherein the fibrous structure is bioabsorbable.

7. The implantable medical device of claim 1 , 3 , 4 or 5 wherein the fibrous structure is non-woven and formed from crimped and stapled fibers.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
SECURITY INTEREST Recorded Oct 1, 2025
From: CORDIS US CORP.; ACCESS CLOSURE, LLC
To: HPS INVESTMENT PARTNERS, LLC
Reel/Frame 072973/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2017
From: CORDIS CORPORATION
To: CARDINAL HEALTH SWITZERLAND 515 GMBH
Reel/Frame 042126/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2009
From: DAVE, VIPUL BHUPENDRA; CHIN-CHEN, CHAO; PALERMO, THOMAS
To: CORDIS CORPORATION
Reel/Frame 023028/0320 →